Neurotoxic effects of (±)fenfluramine and phentermine, alone and in combination, on monoamine neurons in the mouse brain

Synapse

Volumn 30, Issue 3, 1998, Pages 239-246

  Mccann, Una D ^a   Yuan, Jie ^b   Ricaurte, George A ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Dopamine; Fenfluramine; Neurotoxicity; Obesity; Phentermine; Serotonin

Indexed keywords

FENFLURAMINE; PHENTERMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ANOREXIGENIC AGENT; BIOGENIC AMINE; DOPAMINE; NEUROTOXIN; SEROTONIN;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; DOSE RESPONSE; EATING HABIT; FOOD INTAKE; MALE; MONOAMINE NERVE CELL; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; ANIMAL; BODY WEIGHT; BRAIN; CALORIC INTAKE; DRINKING BEHAVIOR; DRUG EFFECT; DRUG INTERACTION; FEEDING BEHAVIOR; METABOLISM; NERVE CELL; PATHOLOGY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; APPETITE DEPRESSANTS; BIOGENIC MONOAMINES; BODY WEIGHT; BRAIN; DOPAMINE; DRINKING BEHAVIOR; DRUG INTERACTIONS; ENERGY INTAKE; FEEDING BEHAVIOR; FENFLURAMINE; HYDROXYINDOLEACETIC ACID; MALE; MICE; NEURONS; NEUROTOXINS; PHENTERMINE; SEROTONIN;

EID: 0031595247     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199811)30:3<239::AID-SYN1>3.0.CO;2-C     Document Type: Article

References (36)

1. Appel, N., Contrera, J., and De Souza, E. (1990) Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: Evidence from immunocytochemical studies. J. Pharmacol. Exp. Ther., 249:928-943.
2. Baumann, M., Scuster, C., and Rothman, R. (1996) Effects of phentermine and cocaine on fenfluramine-induced depletion of serotonin in mouse brain. Drug Alcohol Depend., 41:71-74.
3. Baumgarten, G., Garattini, S., Lorens, S., and Wurtman, R. (1992) Dexfenfluramine and neurotoxicity. Lancet, 339:359-360.
4. Caccia, S., Aneli, M., Ferrrese, A., Fracaso, C., and Garattini, S. (1993) The role of d-norfenfluramine in the indole-depleting effect of fenfluramine. Eur. J. Pharmacol., 233:71-77.
5. Chappell, W., and Mordenti, J. (1989) Extrapolation of lexicological and pharmacological data from animals to humans. In: Advances in Drug Research. B. Testa, ed. Academic Press, San Diego, pp. 1-116.
6. Clineschmidt, B., Zachel, A., Totaro, J., Pflueger, A., and McGuffin, J. (1978) Fenfluramine and brain serotonin. Ann. N.Y. Acad. Sci., 305:222-241.
7. Colado, M., Murray, T., and Green, A. (1993) 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br. J. Pharmacol., 108:583-589.
8. Derome-Tremblay, M., and Nathan, C. (1989) Fenfluramine studies (Letter). Science, 243:991.
9. Fracaso, C., Guiso, G., Confalonieri, S., Bergami, A., Garattini, S., and Caccia, S. (1995) Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the rat. Neuropharmacology, 34:1653-1659.
10. Gibb, J., and Kogan, F. (1979) Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch. Pharmacol., 310:185-187.
11. Harvey, J., and McMaster, S. (1975) Fenfluramine: Evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin. Psychopharmacol. Commun., 1:217-228.
12. Harvey, J., McMaster, S., and Fuller, R. (1977) Comparison between the neurotoxic and serotonin depleting effects of various halogenated derivatives of amphetamine in the rat. J. Pharmacol. Exp. Ther., 202:581-589.
13. Harwood, P. (1963) Therapeutic dosage in small and large mammals. Science, 139:684-685.
14. Hitzig, P. (1994) Combined serotonin and dopamine indirect agonists correct alcohol craving and alcohol-associated neuroses [Letter]. J. Subst. Abuse Treat., 11:489-490.
15. Johnson, M., and Nichols, D. (1990) Comparative serotnin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine. Pharmacol. Biochem. Behav., 36:105-109.
16. Kalia, M. (1991) Reversible, short-lasting, and dose-dependent effect of (+)fenfluramine on neocortical serotonergic axons. Brain Res., 548:111-125.
17. Kleven, M., and Seiden, L. (1989) D-, L-, DL-fenflurne cause long lasting depletions of serotonin in rat brain. Brain Res., 505:351-353.
18. Kleven, M., Schuster, C., and Seiden, L. (1988) Effects of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J. Pharmacol. Exp. Ther., 246:822-828.
19. Kleven, M., Woolverton, W., and Seiden, L. (1991) Evaluation of potential neurotoxic effects of amphetamine-related anorectic agents on brain serotonin and dopamine in the rat. Proc. Soc. Neurosci. Abs., 17:1488.
20. Lew, R., Weisenberg, B., Vosmer, G., and Seiden, L. (1997) Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields. Synapse, 26:36-45.
21. McCann, U., Hatzidimitriou, G., Ridenour, A., Fisher, C., Katz, J., and Ricaurte, G. (1994) Dexfenfluramine neurotoxicity in humans: Further preclinical evidence that concern is warranted. J. Pharmacol. Exp. Ther., 269:792-798.
22. Molliver, D., and Molliver, M. (1990) Anatomic evidence of a neurotoxic effect of (±)fenfluramine upon serotonergic projections in the rat. Brain Res., 511:165-168.
23. Mordenti, J., and Chappell, W. (1989) The use of interspecies scaling in toxicokinetics. In: Toxicokinetics in New Drug Development. A. Yacobi, J. Kelly, and V. Batra, eds. Pergamon Press, New York, pp. 42-96.
24. O'Dell, S., Weihmuller, F., and Marshall, J. (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res., 564:256-260.
25. Ricaurte, G., Molliver, M., Martello, M., Katz, J., Wilson, M., and Martello, A. (1991) Dexfenfluramine neurotoxicity in brains of non-human primates. Lancet, 338:1487-1488.
26. Ricaurte, G., Martello, A., Katz, J., and Martello, M. (1992) Lasting effects of (±)3,4-methylenedioxymethamphetamine on central serotonergic neurons in non-human primates: Neurochemical observations. J. Pharmacol. Exp. Ther., 261:616-622.
27. Rothman, R., Gendron, T., and Hitzig, P. (1994) Hypothesis that mesolimbic dopamine (DA) plays a key role in mediating the reinforcing effects of drugs of abuse as well as the rewarding effects of ingestive behaviors [Letter]. J. Subst. Abuse Treat., 11:273-275.
28. Sanders-Bush, E., Bushing, J., and Sulser, F. (1975) Long-term effects of p-chloro amphetamine and related drugs on central serotonergic mechanisms. J. Pharmacol. Exp. Ther., 192:33-41.
29. Schmidt, C., Ritter, J., Sonsalla, P., Hanson, G., and Gibb, J. (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther., 233:539-544.
30. Schuster, C., Lewis, M., and Seiden, L. (1986) Fenfluramine: Neurotoxicity. Psychopharmacol. Bull., 22:148-151.
31. Sotelo, C. (1991) Immunohistochemical study of short- and long-term effects of d,1-fenfluramine on the serotonergic innervation of the rat hippocampal formation. Brain Res., 541:309-326.
32. Weintraub, M. (1992) Long-term weight control study: Conclusions. Clin. Pharmacol. Ther., 51:642-646.
33. Westphalen, R., and Dodd, P. (1995) The nature of D-L-induced 5-HT re-uptake transporter loss in rats. Mol. Neurobiol., 11:165-175.
34. Woodward, E. (1970) Clinical experience with fenfluramine in the United States. In: Amphetamines and Related Compounds, E. Costa, S. Garattini, eds. New York: Raven Press pp. 685-691.
35. Yanovski S. et al. (1996) National Task Force on the Prevention and Treatment of Obesity: Long-term pharmacotherapy in the management of obesity. JAMA, 276:1907-1915.
36. Zaczek, R., Battaglia, G., Culp, S., Appel, N., Contrera, J., and De Souza, E. (1990) Effects of repeated fenfluramine administration on indexes of monoamine function in rat brain: Pharmacokinetic, dose response, regional specificity and time-course data. J. Pharmacol. Exp. Ther., 253:104-112.